OCEA — Ocean Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00- $0.14m
- $9.49m
Annual cashflow statement for Ocean Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -62.3 | -17.4 | -114 | -9.48 |
| Non-Cash Items | 56.5 | 13.6 | 104 | 4.26 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 4.74 | 2.81 | 1.18 | 1.04 |
| Change in Prepaid Expenses | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -1.05 | -0.993 | -9.43 | -4.18 |
| Financing Cash Flow Items | 0.096 | 0.232 | -10.7 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.11 | 0.967 | 10.4 | 3.4 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.06 | -0.026 | 0.97 | -0.78 |